Fig. 2From: Targeting CD33 for acute myeloid leukemia therapyOS of 86 patients with AML based on the expression level of CD33 (low CD33 and high CD33 expression). P < 0.001. AML, Acute myeloid leukemia; OS, Overall survivalBack to article page